Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Cipla stands strong with India in the battle against COVID-19

Posted On: 2020-04-21 12:21:43


Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced an INR 25 crore fund to support the Indian Government's efforts to effectively combat the COVID-19 pandemic. This includes a voluntary donation of approximately INR 3 crore from Cipla employees who have stepped forward in this hour of national need. Through its wide-ranging relief efforts, the Company is focusing on initiatives that have the maximum impact and reach. It is currently supporting public health institutions, frontline healthcare workers, vulnerable patients and communities struggling in the aftermath.

Of the INR 25 crores set aside for COVID response, the Company has announced a donation of INR 9 crore to the PM CARES Fund. In addition, Cipla has announced a donation of INR 8 crore to different State authorities. These contributions will help to further several immediate and long-term relief efforts that the country needs to combat the size and scale of the crisis it is confronted with. Over and above, Cipla Foundation, the social responsibility arm of Cipla, has committed INR 4 crore towards COVID response programmes, many of which are already underway. The Company has also allocated INR 4 crore towards the supply of essentials including medicines, personal protective equipment, sanitisers, masks, gloves and food. Cipla is committed to combatting the crisis on multiple fronts:

Caring for patients

The company has implemented a spate of stringent safety measures in line with social distancing norms so that manufacturing and distribution of essential medicines can continue despite challenges of remote working. Employees have been working at manufacturing locations and depots, driven to uphold the interest of patients in these difficult times. Additionally, Cipla has also launched a toll-free helpline to assist its patients in procuring essential medication across therapies from pharmacies and healthcare institutions. Through its Foundation, the company has been supporting public health and charitable hospitals to manage the crisis and serve vulnerable patients in need. Since Maharashtra is one of the worst affected, the Foundation has partnered with several hospitals in Mumbai to strengthen the state's healthcare infrastructure to tackle the pandemic. Towards this, the organization has supported the setting-up of a COVID-19 24/7 testing laboratory at JJ Hospital that will benefit over 4,000 patients as well as the city's only isolation ward for pediatric patients suspected of having COVID-19 at the BJ Wadia Hospital for Children. The Cipla Palliative Care & Training Centre in Pune continues to offer 24/7 care to patients and families during this challenging time.

Caring for the healthcare workforce

To safeguard frontline healthcare workers, the Company is supplying essential items like masks, PPE, gloves and sanitizers to over 10,000 doctors, paramedics and associated institutions including tertiary municipal and district hospitals Webinar series are also being organised through industry bodies like the Indian Chest Society, International Diabetes Federation to equip healthcare workers with necessary information on the pandemic. Through its Foundation, the company is aiming to connect doctors and healthcare workers across India with the AIIMS and ICMR led knowledge network on COVID-19 through ECHO India-a technology-based knowledge sharing platform. These online facilities, the first in India for the pandemic, will be set up at leading government and medical colleges.

Caring for the community

In furtherance of its responsibility to the community, Cipla is providing essential supplies, such as medicines, PPEs, food packets, sanitizers, masks, and gloves to those engaged in essential services like the police and public transport operators as well as individuals living near the Company's facilities. Cipla Foundation continues to partner with organizations on the ground as well as with the local administration to reach those most in need.

Shares of CIPLA LTD. was last trading in BSE at Rs.584.75 as compared to the previous close of Rs. 598.1. The total number of shares traded during the day was 246240 in over 7170 trades.

The stock hit an intraday high of Rs. 599.75 and intraday low of 580.15. The net turnover during the day was Rs. 144674871.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Welspun Corp Ltd to create Pipe and Steel verticals

PI Industries Limited to acquire API business division of Ind Swift Laboratories Ltd

MOFSL books Rs. 114 crores profit through sale of equity investments in GR Infraprojects Limited

Evexia Lifecare Limited receives initial plant layout permission from FDA

Info Edge India Ltd invests Rs. 7 crores in 4B Networks

Torrent Power acquires 50 MW Solar Power Plant from Lightsource bp and UKCI

JK Tyre's subsidiary Cavendish Industries Ltd, Q1FY22 Revenues stood at Rs.687 crore, up by 112%

HCL Named a Leader in 2021 Application Modernization and Migration Services Analyst Report

IndiGrid steps up quarterly distribution by 6% YoY

Sunteck Realty Ltd Q1FY22 consolidated net profit at Rs. 3.02 crore

PI Industries Ltd Q1FY22 consolidated PAT up at Rs. 187.2 crores

DiGiSPICE Technologies Ltd Q1FY22 consolidated loss at Rs. 2.42 crore

Britannia Industries Ltd posts consolidated PAT of Rs. 389.55 crores in 1QFY22

Tokyo Finance Ltd Q1FY22 loss at Rs. 3.45 lakhs

Tinna Rubber and Infrastructure Ltd Q1FY22 consolidated PAT climbs to Rs. 3.69 crore

WeP Solutions Ltd Q1FY22 consolidated PAT at Rs. 13.96 lakhs

Jindal Saw Ltd Q1FY22 consolidated PAT slips QoQ to Rs. 152.10 crores

KEC International Ltd Q1FY22 consolidated net profit falls to Rs. 46.14 crore

NELCO Ltd Q1FY22 consolidated net profit at Rs. 4.38 crore

Equitas Small Finance Bank Ltd Q1FY22 PAT declines to Rs. 11.92 crore

Yaarii Digital Integrated Services Ltd Q1FY22 consolidated

Finolex Industries Ltd Q1FY22 consolidated PAT drops QoQ to Rs. 145.52 crores

Dalmia Bharat Sugar and Industries Ltd reports Rs. 124.34 crores consolidated PAT in Q1FY22

GI Engineering Solutions Ltd Q1FY22 PAT at Rs. 2.90 lakhs

Ador Fontech Ltd Q1FY22 consolidated PAT at Rs. 6.25 crore

SORIL Infra Resources Ltd reports consolidated net profit of Rs. 0.53 crore in Q1FY22

NGL Fine-Chem Ltd Q1FY22 consolidated net profit jumps to Rs. 19.12 crores

Macrotech Developers Ltd Q1FY22 consolidated PAT at Rs. 160.91 crores

Indo Amines Ltd Q1FY22 consolidated PAT slides QoQ to Rs. 7.12 crore

COSYN Ltd Q1FY22 consolidated loss at Rs. 72.92 lakhs

Master Trust Ltd posts Rs. 12 crore consolidated PAT in Q1FY22

Basant Agro Tech India Ltd Q1FY22 net profit climbs to Rs. 5.16 crore

Welspun Specialty Solutions Limited reports Q1FY22 results

Shriram Transport Finance Company Ltd Q1FY22 consolidated PAT at Rs. 169.94 crores

Allied Digital Services Ltd Q1FY22 consolidated PAT up at Rs. 4.66 crore

Veto Switchgears and Cables Limited announces Q1FY22 results

Hero MotoCorp commences retail operations in Mexico

JK Paper Limited board approves investment, acquisition

Asahi India Glass Limited and Ahmedabad based Vishakha Group announces partnership

India Grid Trust declares distribution of Rs. 3.1875

United Shippers Limited to transfer Marine Transport and Logistics business through slump sale

V-Guard Industries Ltd forms V-Guard Consumer Products Limited

NSE IFSC lists Indian Railway Finance Corporation's Foreign Currency Bonds and Green Bonds

DRC Systems India Limited announces Q1FY22 Financial Results

Dr. Lal PathLabs Ltd Board declares Interim Dividend of Rs. 6

Zydus Cadila receives final approval from USFDA for Fulvestrant Injection

Allcargo Logistics expands in Europe with ECU Worldwide - Nordicon joint venture

Chandra Prabhu International Ltd Q1FY22 PAT rises to Rs. 7.28 crore

Nazara Technologies Ltd posts Rs. 5.3 crore consolidated PAT in Q1FY22

Rossari Biotech Ltd Q1FY22 consolidated PAT higher at Rs. 24.52 crores


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020